Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
ERIS.NS Stock Summary
In the News
ERIS.NS Financial details
Company Rating
Buy
Market Cap
114.66B
Income
3.86B
Revenue
18.41B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
3.55K
Optionable
No
Shortable
Yes
Earnings
15 May 2024
P/E
32.04
Forward P/E
25.59
PEG
-64.71
P/S
6.97
P/B
5.12
P/C
-
P/FCF
3961.27
Quick Ratio
1.1
Current Ratio
1.93
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
28.41
EPS next Y
32.95
EPS next Q
-
EPS this Y
-5.99%
EPS next Y
15.97%
EPS next 5Y
123.86%
EPS last 5Y
5.85%
Revenue last 5Y
11.43%
Revenue Q/Q
-3.4%
EPS Q/Q
-16.85%
-
-
-
-
SMA20
-2.88%
SMA50
-7.76%
SMA100
-0.94%
Inst Own
-
Inst Trans
-
ROA
10%
ROE
33%
ROC
0.14%
Gross Margin
81%
Oper. Margin
26%
Profit Margin
22%
Payout
-
Shs Outstand
136.03M
Shs Float
33.48M
-
-
-
-
Target Price
-
52W Range
555.0-971.9
52W High
-13.15%
52W Low
+51.95%
RSI
42
Rel Volume
0.25
Avg Volume
235.14K
Volume
59.65K
Perf Week
-0.3%
Perf Month
-2.56%
Perf Quarter
-4.46%
Perf Half Y
1.81%
-
-
-
-
Beta
0.419
-
-
Volatility
2.08%, 20.66%
Prev Close
0.28%
Price
843.35
Change
-0.04%
ERIS.NS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 70.33 | 77.13 | 87.84 | 97.6 | 122.21 | |
Net income per share | 21.15 | 21.61 | 26.16 | 29.89 | 28.1 | |
Operating cash flow per share | 16.22 | 19.76 | 27.64 | 27.84 | 21.45 | |
Free cash flow per share | 13.45 | 8.73 | 25.75 | 18.93 | -40.42 | |
Cash per share | 23.45 | 10.35 | 3.85 | 13.04 | 6.56 | |
Book value per share | 83.66 | 94.49 | 116.1 | 140.45 | 161.49 | |
Tangible book value per share | 33.57 | 36.77 | 58.84 | 85.02 | 0.61 | |
Share holders equity per share | 83.66 | 94.49 | 116.1 | 140.45 | 161.49 | |
Interest debt per share | 14.49 | 1.04 | 0.63 | 6.52 | 66.4 | |
Market cap | 87.5B | 50.61B | 82.15B | 93.58B | 77.79B | |
Enterprise value | 89.19B | 50.06B | 81.85B | 93.91B | 86B | |
P/E ratio | 30.09 | 17.07 | 23.13 | 23.04 | 20.36 | |
Price to sales ratio | 9.05 | 4.78 | 6.89 | 7.06 | 4.68 | |
POCF ratio | 39.24 | 18.67 | 21.88 | 24.74 | 26.67 | |
PFCF ratio | 47.3 | 42.23 | 23.5 | 36.38 | -14.15 | |
P/B Ratio | 7.61 | 3.9 | 5.21 | 4.9 | 3.54 | |
PTB ratio | 7.61 | 3.9 | 5.21 | 4.9 | 3.54 | |
EV to sales | 9.22 | 4.73 | 6.86 | 7.08 | 5.18 | |
Enterprise value over EBITDA | 25.48 | 13.21 | 18.84 | 18.9 | 15.7 | |
EV to operating cash flow | 39.99 | 18.46 | 21.8 | 24.83 | 29.48 | |
EV to free cash flow | 48.21 | 41.77 | 23.41 | 36.51 | -15.65 | |
Earnings yield | 0.03 | 0.06 | 0.04 | 0.04 | 0.05 | |
Free cash flow yield | 0.02 | 0.02 | 0.04 | 0.03 | -0.07 | |
Debt to equity | 0.15 | 0.01 | 0 | 0.04 | 0.4 | |
Debt to assets | 0.11 | 0.01 | 0 | 0.04 | 0.24 | |
Net debt to EBITDA | 0.48 | -0.15 | -0.07 | 0.07 | 1.5 | |
Current ratio | 1.9 | 2.91 | 2.8 | 3.14 | 1.73 | |
Interest coverage | 13.49 | 148.87 | 215.1 | 102.39 | 16.11 | |
Income quality | 0.7 | 0.82 | 0.95 | 0.86 | 0.72 | |
Dividend Yield | 0 | 0.01 | 0.01 | 0.01 | 0.01 | |
Payout ratio | 0 | 0.16 | 0.21 | 0.2 | 0.26 | |
Sales general and administrative to revenue | 0.03 | 0.03 | 0.04 | 0.04 | 0.03 | |
Research and developement to revenue | 0 | 0 | 0 | 0.02 | 0 | |
Intangibles to total assets | 0.46 | 0.51 | 0.42 | 0.33 | 0.6 | |
Capex to operating cash flow | -0.17 | -0.56 | -0.07 | -0.32 | -2.88 | |
Capex to revenue | -0.04 | -0.14 | -0.02 | -0.09 | -0.51 | |
Capex to depreciation | -1.05 | -3.01 | -0.6 | -1.87 | -7.19 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 199.51 | 214.36 | 261.39 | 307.33 | 319.56 | |
ROIC | 0.21 | 0.22 | 0.22 | 0.19 | 0.12 | |
Return on tangible assets | 0.34 | 0.39 | 0.34 | 0.27 | 0.26 | |
Graham Net | 8.07 | 5.58 | 0.9 | 3.08 | -78.63 | |
Working capital | 2.76B | 3.15B | 3B | 4.28B | 3.21B | |
Tangible asset value | 4.62B | 5.04B | 7.99B | 11.55B | 82.32M | |
Net current asset value | 1.97B | 2.24B | 2.09B | 2.63B | -6.82B | |
Invested capital | 0.15 | 0.01 | 0 | 0.04 | 0.4 | |
Average receivables | 1.52B | 1.92B | 2.18B | 2.27B | 2.61B | |
Average payables | 420.63M | 920.88M | 1.01B | 1.1B | 1.21B | |
Average inventory | 740.51M | 760.64M | 819.71M | 1.06B | 1.25B | |
Days sales outstanding | 66.43 | 71.62 | 69.8 | 62.23 | 65.17 | |
Days payables outstanding | 197.92 | 204.32 | 154.86 | 164.83 | 129.25 | |
Days of inventory on hand | 194.45 | 141.88 | 142.56 | 165.02 | 136.15 | |
Receivables turnover | 5.49 | 5.1 | 5.23 | 5.87 | 5.6 | |
Payables turnover | 1.84 | 1.79 | 2.36 | 2.21 | 2.82 | |
Inventory turnover | 1.88 | 2.57 | 2.56 | 2.21 | 2.68 | |
ROE | 0.25 | 0.23 | 0.23 | 0.21 | 0.17 | |
Capex per share | -2.76 | -11.03 | -1.9 | -8.91 | -61.88 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q3
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 30.73 | 29.16 | 33.83 | 36.82 | 35.53 | |
Net income per share | 7.49 | 4.81 | 6.98 | 9.08 | 7.55 | |
Operating cash flow per share | 4.4 | 0.23 | 6.01 | 6.19 | 6.72 | |
Free cash flow per share | 4.4 | 0.23 | 6.01 | 6.19 | 6.72 | |
Cash per share | 5.22 | 6.56 | 6.56 | 14.14 | 0 | |
Book value per share | 151.27 | 161.47 | 163.3 | 177.4 | 0 | |
Tangible book value per share | 0 | 0.61 | 0 | 20.02 | 0 | |
Share holders equity per share | 151.27 | 161.47 | 163.3 | 177.4 | 0 | |
Interest debt per share | 0.22 | 65.11 | 1.28 | 62.22 | 1.33 | |
Market cap | 88.02B | 77.81B | 95.04B | 119.12B | 123.26B | |
Enterprise value | 88.73B | 86.01B | 95.94B | 125.69B | 123.26B | |
P/E ratio | 21.6 | 29.73 | 25.05 | 24.13 | 29.99 | |
Price to sales ratio | 21.07 | 19.62 | 20.66 | 23.8 | 25.49 | |
POCF ratio | 147.21 | 2.49K | 116.21 | 141.49 | 134.81 | |
PFCF ratio | 147.21 | 2.49K | 116.21 | 141.49 | 134.81 | |
P/B Ratio | 4.28 | 3.54 | 4.28 | 4.94 | 0 | |
PTB ratio | 4.28 | 3.54 | 4.28 | 4.94 | 0 | |
EV to sales | 21.24 | 21.69 | 20.85 | 25.11 | 25.49 | |
Enterprise value over EBITDA | 63.63 | 71.74 | 56.19 | 68.08 | 68.59 | |
EV to operating cash flow | 148.39 | 2.76K | 117.3 | 149.3 | 134.81 | |
EV to free cash flow | 148.39 | 2.76K | 117.3 | 149.3 | 134.81 | |
Earnings yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Free cash flow yield | 0.01 | 0 | 0.01 | 0.01 | 0.01 | |
Debt to equity | 0 | 0.4 | 0 | 0.34 | 0 | |
Debt to assets | 0 | 0.24 | 0 | 0.21 | 0 | |
Net debt to EBITDA | 0.51 | 6.84 | 0.52 | 3.56 | 0 | |
Current ratio | 0 | 1.73 | 0 | 1.93 | 0 | |
Interest coverage | 36.49 | 9.56 | 7.42 | 8.75 | 7.4 | |
Income quality | 0.59 | 0.05 | 0.86 | 0.68 | 0.89 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0.3 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0.02 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0.6 | 0 | 0.56 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0.01 | 0 | 0 | 0 | |
Graham number | 159.67 | 132.19 | 160.09 | 190.38 | 0 | |
ROIC | 0.05 | 0.02 | 0.05 | 0.04 | 0 | |
Return on tangible assets | 0 | 0.04 | 0 | 0.07 | 0 | |
Graham Net | 5.22 | -78.61 | 6.56 | -67.65 | 0 | |
Working capital | 709.59M | 3.21B | 892.43M | 4.64B | 0 | |
Tangible asset value | 0 | 82.32M | 0 | 2.72B | 0 | |
Net current asset value | 709.59M | -6.82B | 892.43M | -4.86B | 0 | |
Invested capital | 0 | 0.4 | 0 | 0.34 | 0 | |
Average receivables | 1.48B | 1.48B | 1.48B | 1.77B | 1.77B | |
Average payables | 582.85M | 623.85M | 623.85M | 752.63M | 752.63M | |
Average inventory | 542.6M | 657.18M | 657.18M | 695.45M | 695.45M | |
Days sales outstanding | 0 | 67.33 | 0 | 63.82 | 0 | |
Days payables outstanding | 0 | 154.34 | 0 | 143.21 | 0 | |
Days of inventory on hand | 0 | 162.58 | 0 | 132.33 | 0 | |
Receivables turnover | 0 | 1.34 | 0 | 1.41 | 0 | |
Payables turnover | 0 | 0.58 | 0 | 0.63 | 0 | |
Inventory turnover | 0 | 0.55 | 0 | 0.68 | 0 | |
ROE | 0.05 | 0.03 | 0.04 | 0.05 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
ERIS.NS Frequently Asked Questions
What is Eris Lifesciences Limited stock symbol ?
Eris Lifesciences Limited is a IN stock and trading under the symbol ERIS.NS
What is Eris Lifesciences Limited stock quote today ?
Eris Lifesciences Limited stock price is $843.35 today.
Is Eris Lifesciences Limited stock public?
Yes, Eris Lifesciences Limited is a publicly traded company.